INTRODUCTION
============

*Cryptococcus* spp. are environmental fungal pathogens afflicting immunocompromised patients as well as immunocompetent individuals, causing life-threatening meningoencephalitis ([@B14]; [@B15]; [@B5]; [@B6]; [@B20]; [@B19]). *Cryptococcus* causes approximately one million annual cases of meningoencephalitis globally among AIDS patients, leading to nearly 625,000 deaths ([@B29]). Despite major developments in HIV treatment *Cryptococcus* infection still remains a major threat to AIDS patients, especially in sub-Saharan Africa ([@B41]).

*Cryptococcus neoformans* (*Cn*) is a ubiquitous fungus, found in tree hollows and pigeon droppings. It is present in the environment and in human hosts predominantly in the yeast form; however, *Cn* can assume hyphal and other shapes depending upon its life cycle state or environmental influences ([@B43]; [@B20]; [@B19]). Pathogenic *Cn* infection initiates upon the inhalation of infectious *Cn* particles, which initially disseminate to the lungs and subsequently to the central nervous system via the circulation if the host's immune response does not control fungal proliferation within the lung ([@B20]). An intracellular facultative pathogen, *Cn* can grow and replicate within the phagolysosome of phagocytic cells, such as alveolar macrophages (AMs) and it can also grow in extracellular spaces, such as within the alveoli or in the bloodstream ([@B8]; [@B10]; [@B22]; [@B38]; [@B35]). Because the pathogen rapidly develops drug resistance ([@B28]), and because the number of immunocompromised patients is increasing, there is a constant need for innovative and effective antifungal therapies.

Hydroxyurea (HU), an antineoplastic drug used for treatment of HIV, cancer, and myeloproliferative diseases ([@B18]) slows the progression of DNA replication machinery by reducing the cell's deoxyribonucleotide (dNTP) pool ([@B17]). HU treatment of the budding yeast *Saccharomyces cerevisiae* (*Sc*) results in DNA replication fork slowing, and the formation of a fork-protection complex to guard the cell's replication machinery, activating the replication checkpoint ([@B1]; [@B17]; [@B44]; [@B2]). In the absence of replication proteins, yeast cells become HU sensitive. Interestingly, in addition to DNA replication genes, \~300 genes from various other pathways have been shown to play role in resistance to HU toxicity and the absence of these genes gives rise to HU sensitivity ([@B4]; [@B11]; [@B30]; [@B42]).

Recently, lipid signaling, especially sphingolipid metabolism, has gained recognition for its role in fungal pathogenesis ([@B34]; [@B31]; [@B37]). All yeast cells, including *Cn*, produce inositol-containing sphingolipids instead of choline-containing sphingolipids (e.g., sphingomyelin), and the deletion of the [i]{.ul}nositol [s]{.ul}phingophospholipid phospholipase [C]{.ul} [1]{.ul} (*ISC1*) gene in *Sc* (*Sc isc1*Δ) causes accumulation of inositol-containing sphingolipids ([@B33]; [@B35]). *Cn* is a pathogenic yeast, and deletion of *ISC1* renders it incapable of causing meningoencephalitis ([@B35]). Isc1 has been characterized in *Sc* ([@B33]) and *Cn* ([@B12]) and in *Leishmania* ([@B45]), indicating that this sphingolipid metabolizing enzyme has unique biochemical characteristics. The absence of the *ISC1* gene in *Sc* increases fungal sensitivity to HU and methyl methanesulfonate (MMS) accompanied by cell division arrest and morphological aberrations ([@B4]; [@B25]; [@B40]). Here, we report our studies into the role of *Cn* *ISC1* in the fungal resistance to HU and MMS and their specific effects on the virulence of the pathogenic fungus *Cn*. We show that *Cn* cells lacking the *ISC1* gene are highly sensitive to HU and MMS and form cell clusters upon HU exposure. The absence of *ISC1* in conjunction with HU treatment synergistically reduced *Cn* infection of macrophage-like cells and immunocompetent mice.

MATERIALS AND METHODS {#s1}
=====================

STRAINS AND PLASMIDS
--------------------

Wild type (WT) *Cn* (var. *grubii* serotype A strain H99) and its *isc1*Δ derivative were used in the current study and have been described previously ([@B35]; [@B12]). The *Sc* strain *Jk9-3d a* (*MATa trp1 leu2-3 his4 ura3 ade2 rme1*) and its *isc1*Δ derivative were used and have been described previously ([@B25]; [@B40]).

EXPOSURE TO HU AND MMS
----------------------

YPD plates (1% yeast extract, 2% peptone, and 2% glucose plus 2% agar) containing appropriate concentrations of HU (Sigma; 0, 25, 50, 100, and 200 mM) or MMS (Sigma; 0.033%) were prepared and used within 48 h. Overnight cultures were inoculated in fresh medium at A~600~ of 0.2 and grown at 30°C. Log-phase cultures were adjusted to A~600~ of 0.4 before making 10-fold serial dilutions and plate spotting (2.5 μl). Plasmids pYES-*Sc* *ISC1* and pYES-*Cn* *ISC1* that express *Sc* *ISC1* and *Cn* *ISC1* genes respectively have been described previously ([@B12]). The two plasmids and a control vector were transformed into appropriate strains (WT and *isc1*Δ of *Sc*) and plated on SD/Ura^-^ plates. Then, 10-fold serial dilutions of log-phase liquid cultures in SD/Ura^-^ liquid medium were spotted on SD/Ura^-^ and SD/Ura^-^/HU plates, and the plates were incubated at 30°C, and analyzed at appropriate times before recording the data.

CELLULAR MORPHOLOGY
-------------------

Cells were grown to log-phase as described above, HU (25--200 mM) or MMS (0.033% v/v) was added, and cells were incubated for 5 or 22 h before they were fixed with 3.7% formaldehyde. Cells were washed with phosphate buffered saline (PBS, 50 mM, pH 7) and further suspended in PBS before analyzing them under a Nikon Eclipse (TE2000-5) microscope with a 40×/100× objective lens.

EFFECT OF HU ON INTRACELLULAR GROWTH OF *Cn*
--------------------------------------------

The murine reticulum sarcoma macrophage-like cell line J774A.1 cells were used up to passage \#8. Cells were then plated in 96-well cell culture plates in Dulbecco's minimal essential medium supplemented with 10% fetal bovine serum. WT *Cn* (H99) and its *isc1*Δ derivative were grown overnight in YPD at 30°C. Cells were washed three times in PBS and counted. Approximately 10^5^ cells in DMEM + FBS medium were added with 10 μg/ml of anti-GXM monoclonal antibody 18B7 (kindly provided by Dr. Arturo Casadevall) with 1 mM HU or without HU. Meanwhile the macrophage-like cells were washed off the non-adhered cells and activated with 50 units/ml of recombinant murine gamma interferon (IFNγ) and 0.3 μg/ml of lipopolysaccharide (LPS). The antibody-opsonized *Cn* cells were added to the macrophage cells at an effector-to-target ratio of 1:1. After incubation for 2 h, extracellular *Cn* cells were washed with three changes of warm DMEM medium and fresh medium without or with 1 mM of HU. For one set of the experiments 200 μl sterile water was added to each well and the macrophage-like cells were lysed by pipetting several times. The samples were diluted and an aliquot was spread on YPD agar plate for determining colony forming units (CFUs); this set served as the time-point "zero." The other time points were 6, 12, and 24 h, at which points the supernatant was aspirated and cells were rinsed once with DMEM. Macrophage cells were lysed by adding 200 μl of sterile water and pipetting several times. The samples were diluted and spread on YPD agar plate for determining the CFUs.

For the phagocytic indices (PI) and for photographs, the conditions were same as above except that the macrophage-like cells were grown on glass cover slips. After 2 h of the *Cn* challenge, the cells were washed three times with PBS, fixed with ice-cold methanol, and stained with Giemsa. For the 24-h experiment, cells were washed three times and fresh medium without HU or with 1 mM HU was added and incubated at 37°C in 5% CO~2~. After 24 h the cells were washed three times with PBS, fixed with ice-cold methanol, and stained with Giemsa. Photographs were taken using a Zeiss microscope equipped with charged-coupled device camera. Results for 0 and 24 h time points are shown in the text.

SURVIVAL STUDIES IN MOUSE MODELS
--------------------------------

Mice were anesthetized with a xylazine--ketamine mixture (60 μl, i.p., 5 mg/kg xylazine, 95 mg/kg ketamine). All *Cn* strains were grown in YPD medium for 16--18 h at 30°C. Cells were washed and re-suspended in PBS. Mice were challenged intranasally with 20 μl of the inoculum containing 5 × 10^5^ *Cn* cells. After *Cn* infection, mice were administered HU (0.8 mg/kg every 48 h). Mice were fed *ad libitum* and monitored twice daily for signs of morbidity or pain or clinical signs suggesting meningoencephalitis. Mice exhibiting any of these signs were immediately sacrificed using CO~2~ inhalation followed by cervical dislocation.

STATISTICAL ANALYSIS
--------------------

All data were analyzed by standard Student's *t*-test with *P* values shown in appropriate figures.

RESULTS
=======

ABSENCE OF *ISC1* CAUSES SENSITIVITY TO HU AND MMS IN *Cn* CELLS
----------------------------------------------------------------

*Cryptococcus neoformans* WT and *isc1*Δ cells were analyzed for their response to long-term exposure to HU and MMS. As shown in **Figures [1A](#F1){ref-type="fig"},[B](#F1){ref-type="fig"}**, whereas WT *Cn* cells recovered from HU and MMS stress, *isc1*Δ cells were highly sensitive to both HU and MMS. The HU sensitivity of *Cn isc1*Δ cells was almost comparable to that of *Sc isc1*Δ cells (**Figure [1A](#F1){ref-type="fig"}**). To ensure that the sensitivity to HU and MMS was due to loss of the *ISC1* gene, we examined a *Cn isc1*Δ strain containing reconstituted *ISC1* for HU and MMS tolerance. As shown in **Figures [1A](#F1){ref-type="fig"},[B](#F1){ref-type="fig"}**, the reconstituted strain was resistant to HU and MMS similar to the WT strain, strongly suggesting a role for *Cn* *ISC1* in HU/MMS tolerance. In addition to testing the role of the reconstituted strain for HU and MMS sensitivity, we tested the role of *Cn ISC1* in HU tolerance independently: we expressed the *Cn ISC1* gene in an *Sc isc1*Δ strain and examined whether the former complemented HU sensitivity. As shown in **Figure [1C](#F1){ref-type="fig"}**, whereas the *Sc* WT strain containing a vector showed HU resistance, its *isc1*Δ derivative containing the vector was HU sensitive. In contrast, the *Sc isc1*Δ strain expressing either *Sc ISC1* or *Cn ISC1* (in pYES vector; [@B12]) showed HU resistance, albeit with minor differences (**Figure [1C](#F1){ref-type="fig"}**). All these results show that *Cn* Isc1 plays a key role in HU/MMS tolerance.

![***Cryptococcus neoformans* cells lacking the *ISC1* gene are sensitive to HU and MMS**. **(A)** Ten-fold serial dilutions of log-phase cultures of *C. neoformans* (WT, *isc1*Δ, and *isc1*Δ + *Cn* *ISC1* reconstituted) and *S. cerevisiae* (WT and *isc1*Δ strains) were spotted on plates containing YPD and YPD + HU (50 mM). **(B)** Ten-fold serial dilutions of log-phase cultures of *C. neoformans* (WT, *isc1*Δ, and *isc1*Δ + *Cn* *ISC1* reconstituted) were spotted on YPD and YPD + 0.033% MMS plates. **(C)** *Cn ISC1* complements HU sensitivity of the *S. cerevisiae isc1*Δ strain. Ten-fold serial dilutions of following log-phase cultures were spotted on SD/Ura^-^ and SD/Ura^-^/HU plates: *Sc* WT cells containing pYES vector, *Sc* *isc1*Δ cells containing the pYES vector, *Sc* *isc1*Δ cells containing pYES-*Sc ISC1* and *Sc* *isc1*Δ cells containing pYES-*Cn ISC1*.](fmicb-03-00187-g001){#F1}

ABSENCE OF *ISC1* AFFECTS CELL MORPHOLOGY AND CELL DIVISION IN *Cn* CELLS UPON EXPOSURE TO HU AND MMS
-----------------------------------------------------------------------------------------------------

We examined whether *Cn* *ISC1* controls cell division and cellular morphology under HU stress. *Cn* WT and *isc1*Δ cells were grown in the presence of various concentrations of HU in liquid media and cell morphology was analyzed microscopically. As shown in **Figures [2A](#F2){ref-type="fig"},[B](#F2){ref-type="fig"}**, HU did not affect cell division of WT cells at 25--50 mM concentrations; however, the bud size was relatively large compared to the untreated WT cells. At higher concentrations of HU (100--200 mM) some WT cells had defects in cell division resulting in cell chains. In contrast to the WT cells, cell division in *isc1*Δ cells was severely inhibited at low HU concentrations (25--50 mM) resulting in cell chains and lawns (**Figures [2A](#F2){ref-type="fig"},[B](#F2){ref-type="fig"}**); a few misshapen cells were also seen (data not shown). These data suggest a synergism between HU and the absence of *ISC1* in inhibiting cell division.

![***Cryptococcus neoformans* cells show HU-induced defects in morphology and cell division**. **(A)** *Cn* WT and *isc1*Δ cells were treated with HU overnight and observed under phase contrast microscope (×1000). *Cn* *isc1*Δ cells formed cell chains and clumps upon HU exposure. **(B)** Bar diagrams showing morphological aberrations in untreated and HU-treated *Cn* WT and *Cn* *isc1*Δ cells.](fmicb-03-00187-g002){#F2}

SYNERGISTIC EFFECTS OF HU AND *ISC1* DELETION ON MACROPHAGE INFECTION
---------------------------------------------------------------------

One mechanism by which Isc1 protects *Cn* cells against the host immune response is by increasing the resistance to antifungal activity of macrophages by favoring fungal intracellular growth ([@B35]). HU treatment of macrophages infected by *Toxoplasma gondii*, *Leishmania amazonensis*, *Trypanosoma cruzi*, and *L. mexicana* has been shown to drastically reduce the number of infected cells ([@B27]; [@B24]). Therefore, we tested whether HU would compromise the intracellular growth of *Cn* cells. We first allowed macrophages to internalize *Cn* cells and then treated the macrophages with HU. HU treatment diminished the intracellular growth of WT *Cn* by \~3.5-fold (**Figure [3A](#F3){ref-type="fig"}**). Interestingly, HU treatment completely abolished the growth of *Cn isc1*Δ cells within the macrophages suggesting a strong synergism between HU and *ISC1* deletion. Representative macrophages with *Cn* infection are shown in **Figure [3B](#F3){ref-type="fig"}**. Importantly, inhibition of intracellular growth was not due to HU's effect on phagocytosis because the drug did not inhibit macrophage ingestion of *Cn* (data not shown). We have already demonstrated that a *Cn* *isc1*Δ strain reconstituted with *Cn ISC1* behaves like the WT *Cn* strain in macrophages ([@B35]). Because the *in vitro* experiments were carried out at 30°C and *in vivo* experiments were performed at 37°C, we needed to ensure that the loss of *isc1*Δ cell viability in macrophages was not temperature dependent. Thus, we grew WT and *isc1*Δ cells at 37°C and compared these data with those obtained at 30°C. We observed that the growth pattern of WT and *isc1*Δ at 37°C was similar to those patterns observed at 30°C (data not shown).

![**Synergistic role of HU and *ISC1* deletion on *Cryptococcus* infection of the macrophage-like cell line J774A.1**. **(A)** Phagocytosis assay with macrophage-like cell line J774A.1 cells infected with *Cn* WT or *isc1*Δ cells in the presence/absence of HU (see Materials and Methods). **(B)** *Cn* cells phagocytosed by J774A.1 were grown in the presence/absence of HU and stained with Giemsa after 24 h. Photographs were taken with a Zeiss microscope equipped with a CCD camera. All images were captured under oil immersion (×100). Red arrows indicate the presence/absence of *Cryptococcus* in the phagolysosomes of macrophages. Most phagolysosomes in untreated WT cells contained *Cn* cells, whereas some HU-treated WT cells still contained *Cn* cells. In contrast, most macrophages did not contain *Cn* *isc1*Δ cells regardless of HU treatment.](fmicb-03-00187-g003){#F3}

HU TREATMENT INHIBITS GROWTH OF *Cn* WT AND *isc1*Δ CELLS IN MICE
-----------------------------------------------------------------

We tested the effects of HU on survival and virulence of *Cn* WT and *isc1*Δ strains in mice. Mice were infected with fungal cells and treated with HU as described in Section "Materials and Methods." Interestingly, HU inhibited the proliferation of WT *Cn* cells in mice and significantly prolonged their survival. In addition, we observed that HU acted synergistically when the *ISC1* gene was absent to inhibit *Cn* cell growth. We performed survival and tissue burden studies in mice by infecting them intranasally with *Cn* WT or the *isc1*Δ strain and then treated the mice with HU (0.8 mg/kg every other day). As expected, untreated mice died within 30 days whereas HU-treated mice survived up to 60 days (**Figure [4A](#F4){ref-type="fig"}**). Interestingly, mice infected with *Cn isc1*Δ cells also survived for 60 days regardless of HU treatment (**Figure [4B](#F4){ref-type="fig"}**). HU significantly reduced fungal burden, especially in the lung tissue. Specifically, HU-treatment reduced the number of CFUs in the lung infected with *Cn* WT by \~10-fold from the initial inoculum (**Figure [4C](#F4){ref-type="fig"}**). Remarkably the number of *Cn* *isc1*Δ CFU decreased by \~1,700 fold in HU-treated mice compared to untreated mice. These data suggest a synergistic effect of HU treatment with *ISC1* deletion in increasing host survival by decreasing organ fungal load. The survival of mice infected with WT *Cn* and treated with HU suggests that exposure to HU (at the HU concentration tested) slows down DNA replication and growth of WT cells, allowing the host's immunity to take over the pathogen. The role of *Cn ISC1* in mice experiments was revealed by the CFU of HU-treated WT *Cn*, untreated *isc1*Δ and HU-treated *isc1*Δ cells recovered from lung tissues.

![**Role of HU and *ISC1* deletion on the survival of mice and on lung tissue burden**. **(A)** Survival curve of CBA/J mice upon infection with WT *Cn* in the presence (green) or absence (black) of HU; **(B)** Survival curve of CBA/J mice upon infection with *Cn* *isc1*Δ cells in the presence (red) or absence (blue) of HU. **(C)** Survival of *Cn* cells in lung tissue of CBA/J mice after 60 days of infection. Lung t-issues were collected from mice and *Cn* CFU was counted by plating on YPD plates.](fmicb-03-00187-g004){#F4}

DISCUSSION
==========

Our results show that HU slows down growth of WT *Cn* cells, which helps both mice and macrophages to inhibit further pathogenic growth. This effect is enhanced by deletion of *ISC1*, suggesting that Isc1 and the sphingolipid metabolic pathway in general should be exploited as novel targets for antifungal drug development, either alone or in combination with existing drugs (e.g., HU) to better control cryptococcosis. Of note, all experiments conducted with mice ended on the 60th day of infection when all surviving mice were sacrificed. Thus, we observed no differences in survival between WT and *isc1*Δ cells upon HU treatment; the *isc1*Δ has a significant defect in virulence. However, treatment with HU profoundly diminished *Cn* proliferation in the lung environment compared to untreated cells.

At present, the molecular mechanism of HU inhibition of *Cn* growth is unknown. We hypothesize that *isc1*Δ may be more susceptible than the WT strain because it controls phytoceramide generation ([@B9]) and its decrease in the deletion mutant could affect membrane permeability and thus HU transport. However, this hypothesis was not supported by studies in budding yeast in which the inhibition of DNA synthesis by HU was not enhanced by deletion of *ISC1* ([@B25]).

Of note, HU has been shown to have an anti-proliferative activity on T cells ([@B3]) and to cause neutropenia in humans and mice ([@B13]). Because neutropenia is associated with prolonged survival of *Cn*-infected mice ([@B26]) HU could increase mice survival through neutropenia. However, the neutropenic effect of HU is remarkably linked to the administered HU dose. Almost all patients will develop neutropenia when the administered dose is 20--30 mg/kg/day or greater. However, several studies have shown that such toxicity can be dramatically reduced if the HU dose is decreased to 4--5 mg/kg/day. In mice, HU at 50 mg/kg/day in a sickle cell model does cause a moderate neutropenia, whereas a lower dose of 25 mg/kg/day does not cause neutropenia ([@B21]). The dose used in our mouse experiment was 0.8 mg/kg/every other day, a dose that is 10-fold less that the HU dose that does not produce neutropenia in people and 25- to 50-fold less than the dose that does not produce neutropenia in mice. Thus, due to the very low dose of HU used in our experimentations, we hypothesize that the increased mouse survival is not due to an effect of HU on neutrophils.

We predict that HU (at the concentration tested here) slows *Cn* DNA replication and cell division while host immunity overtakes the pathogen. This effect appears to be enhanced when *Cn* cells are intracellular. This hypothesis is supported by our experiment with macrophage-like cell line showing that HU significantly suppresses fungal cell division within macrophages. Very interestingly, HU has been tested against various intracellular parasites such as *Toxoplasma gondii*, *L. amazonensis*, *Trypanosoma cruzi*, and *L. mexicana* ([@B27]; [@B24]). Not only did HU induce morphological changes in these parasites, but also it inhibited intracellular multiplication of these microbes, similar to the phenotype observed with *Cn* in macrophages illustrated in this paper. In addition, in *L. mexicana* HU induced cell cycle arrest suggesting that the mechanism by which HU inhibits the synthesis of the DNA replication and cell division has been maintained in different microbial species.

A recent study points to an important aspect concerning the use of HU to control cryptococcosis. The authors found that HU enhances post-fusion hyphal extension in *Cn* cells, but not in haploid cells ([@B46]). HU is known to induce morphological changes such as hyphal generation in *Candida albicans* ([@B36]; [@B39]) but in *Sc* it generates limited morphological aberrations (in 1--3% cells) and extensive morphological aberrations are seen in *Sc* mutants on checkpoint, budding and, notably, in the *isc1*Δ deletion mutant ([@B16]; [@B7]; [@B40]). It seems that *Cn* behaves similar to *Sc*; morphological changes by HU (at low concentrations) only occur in *isc1*Δ cells and not in WT cells. In another study it has been shown that certain *Cn* mutants such as *ras1*Δ were sensitive to HU and MMS ([@B23]).

Intriguingly, the morphological changes ascribed to HU are strictly linked to defects in yeast cell division. Possibly, in addition to the inhibition of DNA synthesis, HU also affects actin polymerization/depolymerization during *Cn* cell division and cell wall synthesis ([@B7]; [@B40]). This hypothesis is supported by our previous studies in *Sc* in which we showed that actin depolymerization is inhibited by HU especially in conditions in which *ISC1* is deleted. This will ultimately block cell division or cell proliferation ([@B40]), possibly through the regulation of morphogenesis and DNA integrity checkpoint proteins. The latter hypothesis is also supported by the results presented in this paper in which we show that HU delays the separation of *Cn* *isc1*Δ daughter cells from the mother cell (**Figures [2A](#F2){ref-type="fig"},[B](#F2){ref-type="fig"}**). This delay in cell division of *Cn* cells may expose the *isc1*Δ cells for longer time to intracellular inhibitors (e.g., hydrogen peroxide, nitric oxide) rendering *isc1*Δ even more susceptible to the intracellular compared to the extracellular environment. Considering that the *Cn isc1*Δ is already hypersusceptible to hydrogen peroxide and nitric oxide ([@B35]), the treatment with HU may render the *isc1*Δ cells even more sensitive than WT cells. Thus, it is possible that HU does increase the killing capacity of macrophages indirectly by increasing the exposure of undivided *Cn* cells to intracellular toxins. Finally, in *Sc* HU affects chitin deposition on the cell wall ([@B40]) particularly when *ISC1* is deleted. This observation further supports a role for Isc1 under HU stress in cell division as chitin is an important regulator of cell morphology and cell division in yeasts ([@B32]). These are exciting possibilities that we will explore in the future.
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